Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Edwards Lifesciences reported $1.41B in Cash and Equivalent for its fiscal quarter ending in September of 2023.

Cash And Equivalent Change Date
AtriCure USD 133.01M 65.77M Sep/2023
Baxter International USD 5.79B 4.07B Sep/2023
Becton, Dickinson and Co. USD 1.42B 493M Sep/2023
Cooper Companies USD 120.8M 3.5M Sep/2023
Dexcom USD 643.7M 551.2M Sep/2023
Edwards Lifesciences USD 1.41B 367.5M Sep/2023
Globus Medical USD 279.62M 26.83M Sep/2023
Hologic USD 2.72B 42.5M Sep/2023
ICU Medical USD 197.19M 1.3M Sep/2023
Inogen USD 124.61M 43.08M Sep/2023
Insulet USD 447M 100K Sep/2023
Integra LifeSciences USD 273.73M 35.46M Sep/2023
Intuitive Surgical USD 3.13B 212.6M Sep/2023
Masimo USD 124.4M 26.3M Sep/2023
Merit Medical Systems USD 58.67M 13.41M Sep/2023
Stryker USD 1.86B 459M Sep/2023
Tandem Diabetes Care USD 79.61M 51.14M Sep/2023
Teleflex USD 881.5M 630.68M Sep/2023
Zimmer Biomet Holdings USD 292.1M 27.7M Sep/2023